Sybly Industries Limited announced the resignation of two non-executive directors, Harish and Indrawati, effective October 21, 2026. The departures were disclosed to the BSE under SEBI listing regulations, with both individuals citing personal reasons for their exit from the board.

Harish (DIN: 10871534) and Indrawati (DIN: 10871535) submitted their resignation letters on the same date. The company’s Additional Director, Chirag, signed the disclosure notice on behalf of the Board of Directors. The resignations mark a change in the composition of the board’s non-executive tier.

Director profiles and tenure

Both directors were appointed to the Sybly Industries board in late September 2025. Their brief tenures of approximately one year ended simultaneously due to personal constraints. The filings indicate no inter-se relationship between the directors and other key managerial personnel.

Concurrent directorships

The disclosure reveals that both Harish and Indrawati held directorships in another listed entity, Unishire Urban Infra Limited, alongside their roles at Sybly Industries. They were appointed to Unishire Urban Infra on September 26, 2025, three days prior to joining Sybly Industries.

The resignation letters addressed to the Board of Directors requested that the company take the information on record and comply with all necessary formalities under the Companies Act, 2013, and SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. No specific details regarding the nature of the "unavoidable" personal reasons were provided in the public disclosures.

Sybly Industries Limited appointed Nand Kishore Ray and Dheeraj Kumar as additional executive and non-independent directors effective October 21, 2026. The appointments were approved by the board during a meeting held the same day.

Both appointees are currently directors at Johnson Pharmacare Limited. The company stated that neither individual is related to existing directors or key managerial personnel of Sybly Industries. Additionally, both confirmed they are not debarred from holding office by any regulatory authority.

Board meeting details

The board meeting commenced at 2:15 pm and concluded at 2:45 pm on October 21, 2026. The appointments were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Consent forms (DIR-2) were submitted by both appointees, certifying their eligibility under the Companies Act, 2013.

Director profiles

Nand Kishore Ray, born in 1956, has a background in business. He holds one other directorship at Johnson Pharmacare Limited, where he also serves as the chairperson of the Stakeholders Relationship Committee. His DIN is 11626638.

Dheeraj Kumar, born in 2005, is also engaged in business. He holds one other directorship at Johnson Pharmacare Limited. His DIN is 11666616. The company noted that Mr. Kumar’s father is Mr. Nand Kishor Ray, indicating a familial link between the two new appointees, though the disclosure field for relationship between directors inter se was marked 'Not applicable' in the initial filing summary, likely referring to relationships with existing board members rather than among the new appointees themselves.

Compliance declarations

Both directors submitted self-declarations confirming they are not debarred from accessing the capital market or holding director positions by SEBI or any other authority. They also declared no convictions for offences related to company promotion, formation, or management in the last five years.